ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

MicroRNA-29b reduces myocardial ischemia-reperfusion injury in rats via down-regulating PTEN and activating the Akt/eNOS signaling pathway

Li, Kunsheng; Zhou, Pengyu; Li, Shiliang; Zheng, Shaoyi*; Wang, Dongjin*华中科技大学; 南方医科大学; 南京大学
JOURNAL OF THROMBOSIS AND THROMBOLYSIS2022-1DOI: 10.1007/s11239-021-02535-y
8被引8阅读
引用收藏
分享

摘要

Reperfusion may cause injuries to the myocardium in ischemia situation, which is called ischemia/reperfusion (I/R) injury. The study aimed to explore the roles of microRNA-29b (miR-29b) in myocardial I/R injury. Myocardial I/R injury rat model was established. Differentially expressed miRNAs between the model rats and the sham-operated rats were analyzed. miR-29b expression in myocardial tissues was measured. Gain-of-function of miR-29b was performed, and then the morphological changes, infarct size, myocardial function, oxidative stress, and the cell apoptosis in myocardial tissues were detected. The target relation between miR-29b and PTEN was detected through bio-information prediction and dual luciferase reporter gene assay. Activation of Akt/eNOS signaling was detected. H9C2 cells were subjected to hypoxia/reoxygenation treatment to perform in vitro experiments. I/R rats presented severe inflammatory infiltration, increased infarct size and cell apoptosis, increased oxidative stress and decreased myocardial function. miR-29b was downregulated in I/R rats, and up-regulation of miR-29b reversed the above changes. miR-29b directly bound to PTEN, and overexpression of miR-29b reduced PTEN expression level and increased the protein levels of p-Akt/Akt and p-eNOS/eNOS. In vivo results were confirmed in in vitro experiments. This study provided evidence that miR-29b could alleviate the myocardial I/R injury in vivo and in vitro by inhibiting PTEN expression and activating the Akt/eNOS signaling pathway.

学科与关键词

关键词
miR-29bMyocardial ischemiareperfusion injuryPTENAkteNOS
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
JOURNAL OF THROMBOSIS AND THROMBOLYSIS
发表日期
2022-01
卷期
第 53 卷, 第 1 期
页码
123-135
DOI
10.1007/s11239-021-02535-y
语言
ENGLISH
期刊等级
4区
成果收录
SCIE
资助标注
China Postdoctoral Science Foundation [2020M681559]; Medical Science and Technology Development Foundation, Nanjing Department of Health [YKK20088, ZKX20026]; Affiliated Drum Tower Hospital, Medical School of Nanjing University

作者

  • L

    Li, Kunsheng (第一作者)

    nanjing univ

  • Z

    Zhou, Pengyu

    southern med univ

查看全部 5 位作者收起作者
  • L

    Li, Shiliang

    huazhong univ sci & technol

  • Z

    Zheng, Shaoyi (通讯)

    southern med univ

  • W

    Wang, Dongjin (通讯)

    nanjing univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417